Overview
David Drew is a Hematologist Oncology specialist and a Hematologist in Ft Lauderdale, Florida. Dr. Drew is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Anemia, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, and Lung Cancer. Dr. Drew is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4725 N Federal Hwy Nuclear Medicine, Holy Cross Medical Group, Ft Lauderdale, FL 33308
1309 S Federal Hwy, Holy Cross Medical Group, Fort Lauderdale, FL 33316
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
University Of Miami
Jaime Merchan is a Hematologist Oncology specialist and a Hematologist in Miami, Florida. Dr. Merchan is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Adult Soft Tissue Sarcoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy. Dr. Merchan is currently accepting new patients.
University Of Miami
Rakesh Singal is an Oncologist and a Hematologist in Miami, Florida. Dr. Singal is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, Clear Cell Sarcoma, and Chromophobe Renal Cell Carcinoma. Dr. Singal is currently accepting new patients.
Cancer Center Of South Florida PLLC
Abraham Schwarzberg is a Hematologist and an Oncologist in Palm Springs, Florida. Dr. Schwarzberg is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Drew isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Drew isDistinguished. Learn about Anemia.
- Congenital Antithrombin 3 DeficiencyDr. Drew isDistinguished. Learn about Congenital Antithrombin 3 Deficiency.
- EGFR Positive Lung CancerDr. Drew isDistinguished. Learn about EGFR Positive Lung Cancer.
- Hereditary Resistance to Anti-Vitamin KDr. Drew isDistinguished. Learn about Hereditary Resistance to Anti-Vitamin K.
- Large-Cell Lung CarcinomaDr. Drew isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Advanced
- Adult Immune ThrombocytopeniaDr. Drew isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Blood ClotsDr. Drew isAdvanced. Learn about Blood Clots.
- ChondrosarcomaDr. Drew isAdvanced. Learn about Chondrosarcoma.
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelomonocytic Leukemia (CMML)
- Experienced
- Acute Eosinophilic PneumoniaDr. Drew isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Hepatic Porphyria (AHP)Dr. Drew isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Mountain SicknessDr. Drew isExperienced. Learn about Acute Mountain Sickness.
- Adult Soft Tissue SarcomaDr. Drew isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Drew isExperienced. Learn about Agranulocytosis.
- Alveolar Soft Part SarcomaDr. Drew isExperienced. Learn about Alveolar Soft Part Sarcoma.